Parkside Financial Bank & Trust’s Genmab GMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.18K Hold
334
– – ﹤0.01% 1686
2026
Q1
$8.96K Hold
334
– – ﹤0.01% 1625
2025
Q4
$10.3K Hold
334
– – ﹤0.01% 1566
2025
Q3
$10.2K Hold
334
– – ﹤0.01% 1510
2025
Q2
$6.9K Buy
334
+142
+74% +$2.92K ﹤0.01% 1607
2025
Q1
$3.76K Buy
192
+90
+88% +$1.89K ﹤0.01% 1719
2024
Q4
$2.13K Sell
102
-30
-23% -$659 ﹤0.01% 1616
2024
Q3
$3.22K Hold
132
– – ﹤0.01% 1517
2024
Q2
$3.32K Hold
132
– – ﹤0.01% 1452
2024
Q1
$3.95K Hold
132
– – ﹤0.01% 1391
2023
Q4
$4.2K Buy
+132
New +$4.14K ﹤0.01% 1347

Other funds holding GMAB

Parkside Financial Bank & Trust's GMAB Position: Q2 2026 in Review

Parkside Financial Bank & Trust held its Genmab (GMAB) position steady in Q2 2026 at 334 shares worth $9.18K. The position accounts for ﹤0.01% of the portfolio, ranked #1686.

Parkside Financial Bank & Trust first reported a position in GMAB in Q4 2023 and has held it in 11 quarters since. The position peaked at $10.3K in Q4 2025. 291 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Parkside Financial Bank & Trust held 334 shares of Genmab worth $9.18K as of Q2 2026.
  • Parkside Financial Bank & Trust left its Genmab share count unchanged in Q2 2026.
  • Genmab made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #1686 holding.
  • Parkside Financial Bank & Trust first reported a position in Genmab in Q4 2023 and has held it in 11 quarters since.
  • Parkside Financial Bank & Trust's Genmab position peaked at $10.3K in Q4 2025.
  • 291 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.